In Silico Structural and Functional Characterization of the RSUME Splice Variants

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Gerez, Juan ^a   Fuertes, Mariana ^a   Tedesco, Lucas ^a   Silberstein, Susana ^a,b   Sevlever, Gustavo ^c   Paez Pereda, Marcelo ^d   Holsboer, Florian ^d   Turjanski, Adrián G ^b   Arzt, Eduardo ^a,b,d  

^a CONICET Partner Institute of the Max Planck Society ^*  (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c FLENI   (Argentina)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN VARIANT; REGULATOR PROTEIN; RWD CONTAINING SUMO ENHANCER PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG; ISOPROTEIN; RSUME PROTEIN, HUMAN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BRAIN CANCER; CARBOXY TERMINAL SEQUENCE; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOLECULAR PATHOLOGY; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; RWD CONTAINING SUMO ENHANCER GENE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; ANIMAL; BIOLOGY; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS;

EID: 84874564151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057795     Document Type: Article

References (45)

1. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, et al. (2007) RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 131: 309-323.
2. Castro CP, Giacomini D, Nagashima AC, Onofri C, Graciarena M, et al. (2003) Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells. Endocrinology 144: 693-700.
3. Frischmeyer PA, Dietz HC, (1999) Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8: 1893-1900.
4. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
5. Geiss-Friedlander R, Melchior F, (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956.
6. Doerks T, Copley RR, Schultz J, Ponting CP, Bork P, (2002) Systematic identification of novel protein domain families associated with nuclear functions. Genome Res 12: 47-56.
7. Nameki N, Yoneyama M, Koshiba S, Tochio N, Inoue M, et al. (2004) Solution structure of the RWD domain of the mouse GCN2 protein. Protein Sci 13: 2089-2100.
8. Tong H, Hateboer G, Perrakis A, Bernards R, Sixma TK, (1997) Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system. J Biol Chem 272: 21381-21387.
9. Shan B, Gerez J, Haedo M, Fuertes M, Theodoropoulou M, et al. (2012) RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells. Endocr Relat Cancer 19: 13-27.
10. Semenza GL, (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578.
11. Brahimi-Horn MC, Pouyssegur J, (2009) HIF at a glance. J Cell Sci 122: 1055-1057.
12. Wang GL, Semenza GL, (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90: 4304-4308.
13. Fowkes RC, Vlotides G, (2012) Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas. Endocr Relat Cancer 19: C1-5.
14. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M, (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855.
15. Berman H, Henrick K, Nakamura H, Markley JL, (2007) The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res 35: D301-303.
16. McGuffin LJ, Bryson K, Jones DT, (2000) The PSIPRED protein structure prediction server. Bioinformatics 16: 404-405.
17. Ward JJ, McGuffin LJ, Bryson K, Buxton BF, Jones DT, (2004) The DISOPRED server for the prediction of protein disorder. Bioinformatics 20: 2138-2139.
18. Kelley LA, Sternberg MJ, (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4: 363-371.
19. Mount DW (2007) Using the Basic Local Alignment Search Tool (BLAST). CSH Protoc 2007: pdb top17.
20. VanDemark AP, Hofmann RM, Tsui C, Pickart CM, Wolberger C, (2001) Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell 105: 711-720.
21. Kovalenko OV, Plug AW, Haaf T, Gonda DK, Ashley T, et al. (1996) Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes. Proc Natl Acad Sci U S A 93: 2958-2963.
22. Desterro JM, Rodriguez MS, Hay RT, (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2: 233-239.
23. Melchior F, Schergaut M, Pichler A, (2003) SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci 28: 612-618.
24. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F, (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108: 109-120.
25. Kotaja N, Karvonen U, Janne OA, Palvimo JJ, (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 22: 5222-5234.
26. Kagey MH, Melhuish TA, Wotton D, (2003) The polycomb protein Pc2 is a SUMO E3. Cell 113: 127-137.
27. Hooft RW, Sander C, Vriend G, (1996) Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins 26: 363-376.
28. Eargle J, Wright D, Luthey-Schulten Z, (2006) Multiple Alignment of protein structures and sequences for VMD. Bioinformatics 22: 504-506.
29. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38, 27-38.
30. Stone DH, (1998) Research and the Internet. J Public Health Med 20: 111-112.
31. Laskowski RA, (2009) PDBsum new things. Nucleic Acids Res 37: D355-359.
32. Kalli K, Huntoon C, Bell M, McKean DJ, (1998) Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB. Mol Cell Biol 18: 3140-3148.
33. Rodriguez MS, Dargemont C, Hay RT, (2001) SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 276: 12654-12659.
34. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, et al. (2001) Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 276: 35368-35374.
35. Richard DE, Berra E, Pouyssegur J, (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275: 26765-26771.
36. Post DE, Van Meir EG, (2001) Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells. Gene Ther 8: 1801-1807.
37. Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, et al. (2004) Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 279: 46415-46423.
38. Shima DT, Gougos A, Miller JW, Tolentino M, Robinson G, et al. (1996) Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci 37: 1334-1340.
39. Rupprecht R, Arriza JL, Spengler D, Reul JM, Evans RM, et al. (1993) Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol Endocrinol 7: 597-603.
40. Tanos T, Marinissen MJ, Leskow FC, Hochbaum D, Martinetto H, et al. (2005) Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 280: 18842-18852.
41. Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, et al. (2002) Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol 16: 1638-1651.
42. Liberman AC, Refojo D, Druker J, Toscano M, Rein T, et al. (2007) The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J 21: 1177-1188.
43. Liberman AC, Druker J, Refojo D, Holsboer F, Arzt E, (2009) Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J 23: 1558-1571.
44. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, et al. (2003) Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci U S A 100: 1034-1039.
45. Ke J, Liu Y, Long X, Li J, Fang W, et al. (2007) Up-regulation of vascular endothelial growth factor in synovial fibroblasts from human temporomandibular joint by hypoxia. J Oral Pathol Med 36: 290-296.